BIO-RAD laboratories, INC. CSP, QX200 digital PCR W/ADG OS digital PCR systems W/auto DG service contract

Closed Pre-Solicitation Posted

Solicitation number
25-000057
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Clinical Center (CC), Center for Cellular Engineering (CCE) intends to award a fixed price contract on a sole source basis to Bio-Rad Laboratories, Inc. for a service contract on two QX200 AutoDG ddPCR Systems. The service contract will provide proprietary parts, remote diagnostic, field service support, preventative maintenance, and software upgrades. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, and interested parties may identify their interest and capabilities in response to this posting by the due date of November 9, 2024.

The two QX200 AutoDG ddPCR Systems are currently owned by the Center for Cellular Engineering (CCE) and are used for accurately assessing gene modification efficiency in clinically engineered cell products. This service contract is for a twelve (12) month base year and four (4) option years, and Bio-Rad Laboratories, Inc. is the sole manufacturer and service provider for the instruments. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Notice text

BIO-RAD LABORATORIES, INC. CSP, QX200 DIGITAL PCR W/ADG OS DIGITAL PCR SYSTEMS W/AUTO DG SERVICE CONTRACT

  • Product Service Code: J066
  • NAICS Code: 811210
  • Place of Performance: Bethesda, MD

POTS: 25-000057

Description

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Clinical Center (CC), Center for Cellular Engineering (CCE) intends to award a fixed price contract on a sole source basis to Bio-Rad Laboratories, Inc., 2000 Alfred Nobel DR Hercules, California

94547-1801 for a twelve (12) month base year and four (4) option years for a service contract on two QX200 AutoDG ddPCR Systems (Serial Number: 771BR3558/773BR1880 & Serial Number: 773BR2063/771BR4088).

The Center for Cellular Engineering (CCE) currently owns two (2) Bio-Rad QX200 AutoDG ddPCR Systems. The instruments are used for accurately assessing gene modification efficiency in clinically engineered cell products. The assessment provides vital data that informs treatment decisions, ultimately enhancing the effectiveness of cellular therapy products administered to patients. Preventative Maintenance is necessary to ensure that the instruments are within the manufacturer standards and in compliance with the Food and Drug Administration (FDA) regulations (21 CFR 211.67). Bio-Rad is the sole manufacturer and service provider for both instruments.  The service contract will provide proprietary parts, remote diagnostic, field service support, preventative maintenance, and software upgrades.  Bio-Rad does not have third-party providers and only Bio-Rad service technicians are authorized to perform service on its equipment.  If a third-party service provider performs any services on the equipment, it may violate the manufacturer’s warranty.  The continuation of the service contract is imperative in ensuring that the equipment stays within its operational state.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe, Contract Specialist, lowet2@mail.nih.gov by the due date 11/09/2024 and 12PM time marked in this notice.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Annual Preventative Maintenance and Service Support for Seven (7) Miltenyi CliniMACS Prodigy Instruments Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Preventative Maintenance and FullCare Service Support for Cytiva Sepax C-PRO Cell Separation Systems Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Preventative Maintenance and Service Support for Miltenyi Biotec CliniMACS Plus Instruments Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors